Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrabali Ghose

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Emerging Microbes & Infections|June 4, 2015
Clostridium difficile infection in the twenty-first centuryChandrabali Ghose
Antibiotics (Basel, Switzerland)|February 15, 2020
Gram-Negative Bacterial LysinsChandrabali Ghose, Chad W Euler
Infectious Disease Clinics of North America|February 14, 2015
The prospect for vaccines to prevent Clostridium difficile infectionChandrabali Ghose, Ciarán P Kelly
BMC Genomics|January 19, 2006
Evidence of host-virus co-evolution in tetranucleotide usage patterns of bacteriophages and eukaryotic virusesDavid T Pride, Trudy M Wassenaar, Chandrabali Ghose, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Immune-based treatment and prevention of Clostridium difficile infectionSong Zhao, Chandrabali Ghose-Paul, Keshan Zhang, et al.
Anaerobe|December 22, 2015
Immunogenicity and protective efficacy of Clostridium difficile spore proteinsChandrabali Ghose, Ioannis Eugenis, Adrianne N Edwards, et al.
Antibiotics (Basel, Switzerland)|June 25, 2025
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United StatesAhnika Kline, Ana G Cobián Güemes, Jennifer Yore, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2002
East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriageChandrabali Ghose, Guillermo I Perez-Perez, Maria-Gloria Dominguez-Bello, et al.
Infection and Immunity|April 3, 2013
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile diseaseChandrabali Ghose, Janneke M Verhagen, Xinhua Chen, et al.
Emerging Microbes & Infections|February 4, 2016
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCChandrabali Ghose, Ioannis Eugenis, Xingmin Sun, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Emerging Microbes & Infections|June 4, 2015
Clostridium difficile infection in the twenty-first centuryChandrabali Ghose
Antibiotics (Basel, Switzerland)|February 15, 2020
Gram-Negative Bacterial LysinsChandrabali Ghose, Chad W Euler
Infectious Disease Clinics of North America|February 14, 2015
The prospect for vaccines to prevent Clostridium difficile infectionChandrabali Ghose, Ciarán P Kelly
BMC Genomics|January 19, 2006
Evidence of host-virus co-evolution in tetranucleotide usage patterns of bacteriophages and eukaryotic virusesDavid T Pride, Trudy M Wassenaar, Chandrabali Ghose, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Immune-based treatment and prevention of Clostridium difficile infectionSong Zhao, Chandrabali Ghose-Paul, Keshan Zhang, et al.
Anaerobe|December 22, 2015
Immunogenicity and protective efficacy of Clostridium difficile spore proteinsChandrabali Ghose, Ioannis Eugenis, Adrianne N Edwards, et al.
Antibiotics (Basel, Switzerland)|June 25, 2025
Current Clinical Laboratory Challenges to Widespread Adoption of Phage Therapy in the United StatesAhnika Kline, Ana G Cobián Güemes, Jennifer Yore, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2002
East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriageChandrabali Ghose, Guillermo I Perez-Perez, Maria-Gloria Dominguez-Bello, et al.
Infection and Immunity|April 3, 2013
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile diseaseChandrabali Ghose, Janneke M Verhagen, Xinhua Chen, et al.
Emerging Microbes & Infections|February 4, 2016
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCChandrabali Ghose, Ioannis Eugenis, Xingmin Sun, et al.
Pageof 2